• Definition & Associations
    • Also known as Samter’s Triad (Classic USMLE triad):
      1. Asthma
      2. Chronic Rhinosinusitis with Nasal Polyps
      3. Hypersensitivity to Aspirin/NSAIDs
    • Not an IgE-mediated reaction (Pseudoallergy).
  • Pathophysiology
    • Mechanism: Dysregulation of arachidonic acid metabolism.
    • COX-1 inhibition by Aspirin/NSAIDs removes the “brake” on the 5-lipoxygenase (5-LOX) pathway.
    • Result: Shunting of arachidonic acid towards leukotriene production.
    • Cysteinyl Leukotrienes (LTC4, LTD4, LTE4): Potent bronchoconstrictors and promoters of vascular permeability/mucus production.
    • PGE2: Loss of anti-inflammatory prostaglandin that typically inhibits 5-LOX.
  • Clinical Features
    • Patient Profile: Adult-onset asthma, chronic congestion, anosmia (loss of smell).
    • Reaction: Ingestion of Aspirin or COX-1 inhibiting NSAIDs triggers acute symptoms within 30 mins to 3 hours:
      • Severe bronchospasm (wheezing, chest tightness)
      • Rhinorrhea/congestion
      • Facial flushing
    • Nasal Polyps: Often visualized on physical exam (pale, gray, teardrop-shaped growths in nasal cavity).
  • Diagnosis
    • Primarily clinical based on history (The Triad).
    • Aspirin Challenge: Gold standard (performed under medical supervision) but rarely required if history is classic.
    • CT Sinuses: Shows pansinusitis and polyposis.
  • Treatment & Management
    • Avoidance: Strictly avoid Aspirin and all NSAIDs (use Acetaminophen or COX-2 inhibitors like Celecoxib cautiously).
    • Pharmacotherapy:
      • Leukotriene receptor antagonists (LTRAs): Montelukast, Zafirlukast (Target the pathway directly).
      • 5-LOX Inhibitors: Zileuton (Blocks leukotriene synthesis).
      • Biologics: Dupilumab (anti-IL-4/IL-13) or Omalizumab (anti-IgE) for severe refractory polyps/asthma.
    • Aspirin Desensitization:
      • Indicated if the patient requires aspirin for cardiovascular/cerebrovascular protection or if symptoms are refractory to medical management.
      • Involves gradual administration of increasing aspirin doses to deplete leukotrienes.
    • Surgery: Endoscopic sinus surgery (polypectomy) for symptomatic relief (recurrence is common).